ADVANZ PHARMA EUROPE LIMITED
DASHWOOD HOUSE, 69 OLD BROAD STREET, LONDON EC2M 1QS- Active
- Private Limited Company
- Company No. 10152652
- Last Updated: 01 Mar 2024
Company Profile
ADVANZ PHARMA EUROPE LIMITED was incorporated on Thursday, April 28, 2016 as a Private Limited Company with registered address in LONDON. ADVANZ PHARMA EUROPE LIMITED has the status: Active and it's listed in the following category: Wholesale of pharmaceutical goods. This Private Limited Company has been operating for 8 years 6 months and 15 days.
| Name | ADVANZ PHARMA EUROPE LIMITED |
|---|---|
| Company number | 10152652 |
| Company type | Private Limited Company |
| Incorporation date | 28 Apr 2016 |
| Status | Active |
| Industry (SIC 2007) |
Address
| Registered Address |
DASHWOOD HOUSE 69 OLD BROAD STREET LONDON EC2M 1QS |
|---|---|
| Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
| Name | Nature of Control |
|---|---|
| Mercury Pharma Group Limited 69 Old Broad Street, EC2M 1QS |
Dates: Friday, July 1, 2022 - present
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
| Intercept Pharmaceuticals, Inc. Hudson Yards, 37th Floor, 10001 |
Dates: Thursday, April 28, 2016 - Friday, July 1, 2022
ownership of shares 75 to 100 percent
voting rights 75 to 100 percent
right to appoint and remove directors
|
Accounts and Confirmation
| Type of accounts | FULL |
|---|---|
| End of financial Year | 31 December |
| Next annual accounts due | 30 September 2024, (-44 days left) |
| Latest accounts | 31 December 2022 |
| Next confirmation statement due | 26 May 2017 |
| Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against ADVANZ PHARMA EUROPE LIMITED.
Previous Names
| Name | Change Date |
|---|---|
| ADVANZ PHARMA EUROPE LIMITED | 28 Apr 2016 |
| INTERCEPT PHARMA LTD | 26 Sep 2022 |